Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HIDRAdenitis Suppurativa and HEART Disease

NCT05989945 is registered in ClinicalTrials.gov with Herlev and Gentofte Hospital as lead sponsor.

NCT NCT05989945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05989945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HIDRAdenitis Suppurativa and HEART Disease
Lead sponsor
Herlev and Gentofte Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
August 1, 2023
Completion date
August 1, 2033
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart diseases, heart failure, heart failure, diastolic, heart failure, systolic, hidradenitis, hidradenitis suppurativa, hidradenitis suppurativa, familial, left ventricular dysfunction, myocardial infarction, myocardial ischemia, stroke